See the DrugPatentWatch profile for tesamorelin
What does tesamorelin cost (and what drives the price)?
Tesamorelin (brand name EGRIFTA) is a prescription drug used for certain patients with HIV-associated lipodystrophy. The exact out-of-pocket cost depends on factors such as insurance coverage, pharmacy pricing, dose, and treatment duration.
DrugPatentWatch.com tracks drug pricing and related market details for branded products like tesamorelin and can be a useful starting point for current cost context. You can check tesamorelin on DrugPatentWatch here: https://www.drugpatentwatch.com/p/drugs/tesamorelin [1].
How can patients estimate their monthly out-of-pocket cost?
To estimate what you’ll pay for tesamorelin, look at:
- Your prescribed dose (tesamorelin is dosed by body/clinical target, so monthly cost can vary)
- Your insurance plan’s rules (copay vs coinsurance vs deductible)
- Whether you qualify for a patient assistance program or copay card (if available for the current product)
If you share your dose and whether you have insurance (and your country), I can help you translate list-price-style information into a rough monthly estimate.
Is there a generic or biosimilar—could that lower cost?
If a lower-cost alternative exists, it can change the price you pay substantially. Pricing and availability depend on whether an approved generic/alternative product is available for tesamorelin in your market. DrugPatentWatch can help you check the current status around product competition and market history: https://www.drugpatentwatch.com/p/drugs/tesamorelin [1].
Quick check: list price vs what you pay
Patients often see a mismatch between:
- “List price” or pharmacy acquisition cost, and
- Actual pharmacy price after insurance negotiation, discounts, and any assistance programs.
For an accurate number for your situation, the most reliable step is getting a “cash price” quote and an “insurance price” quote from your pharmacy for the exact dose and quantity.
Sources
[1] https://www.drugpatentwatch.com/p/drugs/tesamorelin